Viratech Corp. (PINKSHEETS: VIRA), the first open source biotech research social network platform, announced today that it has published its e-Book on open source biotech research. The book, "Open Source Cancer Research," by Dr. Kevin Buckman, describes how the first open source biotech research social network platform works to make it possible for individuals or smaller companies to compete with larger companies in the race to patent new medicines or technology. The book can be purchased at: http://www.amazon.com/Open-Source-Cancer-Research-ebook/dp/B00BL8N3TA.
Popular products such as Mozilla Firefox, Google Chromium, Android and the Apache Open Office Suite, were all developed with open source. Viratech's patent-pending method of allowing open source research and development of biotech inventions is designed to allow biotech the same advancements as the IT industry enjoyed in open source research and development of software which led to the huge current advance in information technology. Its premise is simply to use the social networking phenomena of Facebook, Twitter and LinkedIn, and apply it to the biotech world, where many new treatments and diagnostics are either gobbled up by Big Pharma and never developed, or never developed for lack of IP protection and financing.
IP protection is complemented by the elements of Promotion and Production of the technology, all using custom tailored interactive pages within the Viratech Social Network, called Micro Social Networks (MSN), owned by each user of the site who creates a page. Any user generated content that is contributed to the MSN owner's page is, by Viratech's terms of service and a separate permission layer, owned by that MSN owner and protected by his or her copyright. This mechanism marks the first time that user generated content on a social network can be utilized in converting traditional patents into copyrighted work products.
Each MSN user can promote their technologies by broadcasting them through a newswire service, which gets picked up on Google through the key words in each article. Readers of the article are met by a pop-up that asks them to join the MSN which, when they join, allows the owner of the MSN to apply their activity in the expanding copyrighted body of knowledge.
Viratech sees their intellectual property as having the potential in creating a paradigm shift in health care, resulting in faster development of new therapies and diagnostics.
Viratech Corp. (PINKSHEETS: VIRA), the first open source biotech research social network platform, announced today that it has published its e-Book on open source biotech research. The book, "Open Source Cancer Research," by Dr. Kevin Buckman, describes how the first open source biotech...